Studying checkpoint blockers and other new immunotherapies is challenging in traditional mouse models because the animals lack B and T cells and have impaired innate immunity. To address these shortcomings, researchers are making progress in reconstituting the human immune system in immunodeficient mouse models.
from Cancer via ola Kala on Inoreader http://ift.tt/2arRYMM
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου